Natamycin 5% Eye Drops
Brand names: Natacyn
Natamycin eye drops are a topical polyene antifungal used to treat fungal infections of the eye, particularly fungal keratitis and fungal conjunctivitis.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It binds to ergosterol in the fungal cell membrane, disrupting membrane integrity and causing leakage of cellular contents, which produces a fungicidal effect against susceptible fungi.
Prescribing in practice
- Fungal keratitis is a sight-threatening infection that requires specialist ophthalmology management and close follow-up, as treatment is often prolonged.
- It is a suspension that should be shaken before use, and poor adherence of the drug to the corneal surface can limit penetration into deeper infection.
- Lack of clinical improvement may indicate a resistant organism or a non-fungal cause and warrants reassessment.
Monitoring
Treatment is monitored by frequent slit-lamp examination to track healing of the corneal lesion and is continued until resolution is confirmed.
Counselling the patient
- Shake the bottle well before each use and instil exactly as directed, as treatment may be needed for a prolonged period.
- Attend all follow-up appointments so the cornea can be examined closely.
- Report any worsening pain, redness or visual loss without delay.
Evidence & guidelines
Natamycin is an established first-line topical antifungal for filamentous fungal keratitis, supported by comparative trial evidence and the SPC.
Reference: MUTT Trial (NEJM 2012); RCOphth Microbial Keratitis Guidelines; AAO Fungal Keratitis PPP; SPC Natacyn; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme